SCHEMBL6650504

SCHEMBL6650504

CC(COC(c1ccc(Cl)cc1)c1cnn(C)c1)N1CCCC1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 1/20 0.46
MEN1 O00255 2/20 0.44
KMT2A Q03164 2/20 0.44
CYP3A4 P08684 3/20 0.43
SLC6A2 P23975 3/20 0.43
SLC6A4 P31645 3/20 0.43
SLC6A3 Q01959 3/20 0.43
CYP2D6 P10635 2/20 0.43
CHRM2 P08172 2/20 0.43
HTR1A P08908 2/20 0.43
ADRA2A P08913 2/20 0.43
CHRM1 P11229 2/20 0.43
DRD1 P21728 2/20 0.43
TBXA2R P21731 2/20 0.43
ADRA1A P35348 2/20 0.43
OPRM1 P35372 2/20 0.43
DRD3 P35462 2/20 0.43
KCNH2 Q12809 2/20 0.43
CYP1A2 P05177 1/20 0.43
TSHR P16473 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6649954 0.90 MEN1 (0.41) POLBMEN1KMT2ACYP3A4SLC6A2
SCHEMBL4909564 0.79 SLC6A4 (0.57) POLBMEN1KMT2ACYP3A4SLC6A2
SCHEMBL4911570 0.75 SLC6A2 (0.41) POLBMEN1KMT2ACYP3A4SLC6A2
SCHEMBL4909463 0.74 CYP3A4 (0.44) MEN1KMT2ACYP3A4SLC6A2SLC6A4
SCHEMBL4908698 0.74 SLC6A2 (0.54) POLBCYP3A4SLC6A2SLC6A4SLC6A3
SCHEMBL4902168 0.74 CYP3A4 (0.46) MEN1KMT2ACYP3A4SLC6A2SLC6A4
SCHEMBL4908712 0.73 CYP3A4 (0.42) CYP3A4SLC6A2SLC6A4SLC6A3CYP2D6
SCHEMBL4908219 0.71 SLC6A2 (0.46) MEN1KMT2ACYP3A4SLC6A2SLC6A4
SCHEMBL4900519 0.71 CYP3A4 (0.41) CYP3A4SLC6A2SLC6A4SLC6A3CYP2D6
SCHEMBL6674616 0.70 SLC6A2 (0.41) MEN1KMT2ACYP3A4SLC6A2SLC6A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1103243-B1 UTILIZATION OF ARYL(OR HETEROARYL)AZOLYLCARBINOL DERIVATIVES FOR THE TREATMENT OF TROUBLES MEDIATED BY AN EXCESS OF SUBSTANCE P ESTEVE LABOR DR (ES) 2004-01-07 EP claimed